FirstLine Consulting Group provides in-depth analyses
of drugs in development to a limited group of buy-side investors.
We produce comprehensive independent research which
includes clinical trial analysis, potential for commercial impact,
competitive assessment and regulatory information.
Our work is used by clients in the healthcare sector
who require greater depth and accuracy in decision making regarding
their investments. We provide syndicated reports as well as customized
consulting for our clients.
Our Ahead of the Curve™ reports deliver detailed
information to investors far ahead of actual data release to maximize
investments. Our evidence-based, unbiased research has been considered
some of the best on the Street.